Highly conserved CDR3 region in circulating CD4⁺V5⁺ T cells may be associated with cytotoxic activity in Chagas diseaseMENEZES, C. A. S; SULLIVAN, A. K; FALTA, M. T et al.Clinical and experimental immunology (Print). 2012, Vol 169, Num 2, pp 109-118, issn 0009-9104, 10 p.Article

DRB1^*04 and DQ alleles : Expression of 21-hydroxylase autoantibodies and risk of progression to Addison's diseaseLIPING YU; BREWER, K. W; REWERS, M. J et al.The Journal of clinical endocrinology and metabolism. 1999, Vol 84, Num 1, pp 328-335, issn 0021-972XArticle

Local immunosuppression of canine renal allografts with 15-deoxyspergualinHUGHES, S. E; XIAO, S; LEMPERT, N et al.Transplantation proceedings. 1996, Vol 28, Num 4, pp 2054-2055, issn 0041-1345Conference Paper

Assessment of the in vivo immunosuppressive activity of the major cyclosporine metabolite by leukemia allograft rejectionFREED, B. M; BENNETT, J. A; ROSANO, T. G et al.Transplantation. 1992, Vol 53, Num 2, pp 456-460, issn 0041-1337Conference Paper

Symposium overview: Alterations in cytokine receptors by xenobioticsCOHEN, M. D; SCHOOK, L. B; OPPENHEIM, J. J et al.Toxicological sciences (Print). 1999, Vol 48, Num 2, pp 163-169, issn 1096-6080Article

Differential inhibition of DNA synthesis in human T cells by the cigarette tar components hydroquinone and catecholLI, Q; AUBREY, M. T; CHRISTIAN, T et al.Fundamental and applied toxicology (Print). 1997, Vol 38, Num 2, pp 158-165, issn 0272-0590Article

Ganciclovir prophylaxis of cytomegalovirus diseaseCONTI, D. J; SHEN, G; SINGH, T et al.Transplantation proceedings. 1997, Vol 29, Num 1-2, pp 804-806, issn 0041-1345Conference Paper

Prophylactic immunoglobulin therapy improves the outcome of renal transplantation in recipients at risk for primary cytomegalovirus diseaseCONTI, D. J; FREED, B. M; LEMPERT, N et al.Transplantation proceedings. 1993, Vol 25, Num 1, pp 1421-1422, issn 0041-1345, 2Conference Paper

Reversal of hydroquinone-mediated suppression of T cell proliferation by transfection of the M2 subunit of ribonucleotide reductaseQING LI; KASTEN-JOLLY, J; YUN YEN et al.Toxicology and applied pharmacology. 1998, Vol 150, Num 1, pp 154-157, issn 0041-008XArticle

Human fibroblasts inhibit production of insulin by the HIT-T15 cell lineCONTI, D. J; AUBREY, M. T; LEMPERT, N et al.Transplantation proceedings. 1992, Vol 24, Num 6, pp 2913-2914, issn 0041-1345Conference Paper

The effects of immunosuppressive agents on in vitro production of human immunoglobulinsSTEVENS, C; LEMPERT, N; FREED, B. M et al.Transplantation. 1991, Vol 51, Num 6, pp 1240-1244, issn 0041-1337, 5 p.Article

In vitro immunosuppressive properties of cyclosporine metabolitesFREED, B. M; ROSANO, T. G; LEMPERT, N et al.Transplantation. 1987, Vol 43, Num 1, pp 123-127, issn 0041-1337Conference Paper

Suppression of human IL-1β, IL-2, IFN-γ, and TNF-α production by cigarette smoke extractsYANLI OUYANG; VIRASCH, N; PING HAO et al.Journal of allergy and clinical immunology. 2000, Vol 106, Num 2, pp 280-287, issn 0091-6749Article

Calcium-mediated induction of anergy in the Jurkat T-cell lineGALLICHIO, M. H; CONTI, D. J; LEMPERT, N et al.Transplantation proceedings. 1994, Vol 26, Num 6, pp 3458-3459, issn 0041-1345Conference Paper

Assessment of the biological activity of cyclosporine metabolites using the human JURKAT cell lineFREED, B. M; STEVENS, C; BROOKS, C et al.Transplantation proceedings. 1991, Vol 23, Num 1, pp 980-981, issn 0041-1345, 2Conference Paper

Identification and characterization of a soluble suppressor factor(s) in the serum of AKR mice bearing lymphocytic leukemiaSIMON, J. D; FREED, B. M; DAVIGNON, D et al.Cellular immunology (Print). 1983, Vol 82, Num 1, pp 163-173, issn 0008-8749Article

Selective cellcept therapy in high-risk renal transplant recipientsISENBERG, A; SINGH, T. P; SHEN, G. K et al.Transplantation proceedings. 1998, Vol 30, Num 4, pp 1188-1189, issn 0041-1345Conference Paper

Inhibition of human T lymphoblast proliferation by hydroquinoneLI, Q; GEISELHART, L; MITTLER, J. N et al.Toxicology and applied pharmacology. 1996, Vol 139, Num 2, pp 317-323, issn 0041-008XArticle

RO 31-8220, a novel protein kinase C inhibitor, inhibits early and late T cell activation eventsGEISELHART, L; CONTI, D. J; FREED, B. M et al.Transplantation. 1996, Vol 61, Num 11, pp 1637-1642, issn 0041-1337Article

Inhibition of interleukin-2 production in the human T cell line JURKAT by nonpolar maleimidesFREED, B. M; LEMPERT, N; LAWRENCE, D. A et al.Toxicology and applied pharmacology. 1991, Vol 107, Num 1, pp 173-182, issn 0041-008X, 10 p.Article

Immunosuppressive metabolites of cyclosporine in the blood of renal allograft recipientsROSANO, T. G; FREED, B. M; CERILLI, J et al.Transplantation. 1986, Vol 42, Num 3, pp 262-267, issn 0041-1337Article

DR- and DQ-associated protection from Type 1A diabetes : Comparison of DRB1*1401 and DQA1*0102-DQB1*0602*REDONDO, M. J; KAWASAKI, E; RONNINGEN, K. S et al.The Journal of clinical endocrinology and metabolism. 2000, Vol 85, Num 10, pp 3793-3797, issn 0021-972XArticle

The cigarette tar component p-benzoquinone blocks T-lymphocyte activation by inhibiting interleukin-2 production, but not CD25, ICAM-1, or LFA-1 expressionGEISELHART, L. A; CHRISTIAN, T; MINNEAR, F et al.Toxicology and applied pharmacology. 1997, Vol 143, Num 1, pp 30-36, issn 0041-008XArticle

Preemptive ganciclovir therapy in cytomegalovirus-seropositive renal transplants recipients. DiscussionCONTI, D. J; FREED, B. M; SINGH, T. P et al.Archives of surgery (Chicago, IL. 1960). 1995, Vol 130, Num 11, pp 1217-1222, issn 0004-0010Conference Paper

Prophylaxis of primary cytomegalovirus disease in renal transplant recipients : a trial of ganciclovir vs immunoglobulinCONTI, D. J; FREED, B. M; GRUBER, S. A et al.Archives of surgery (Chicago, IL. 1960). 1994, Vol 129, Num 4, pp 443-447, issn 0004-0010Article